Covered recipient · General Payments record
DUSTIN W HALL
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2023
$2,310.40
- Reported across 109 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $272.98 | 12 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alkermes, Inc. | $99.13 | 4 |
| Indivior Inc. | $55.19 | 2 |
| Neurocrine BioSciences, Inc. | $49.01 | 2 |
| BioXcel Therapeutics, Inc. | $35.42 | 2 |
| Lundbeck LLC | $34.23 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alkermes, Inc. | $24.99 | 01/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022828853 | CMS |
| Alkermes, Inc. | $23.14 | 03/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022828855 | CMS |
| Alkermes, Inc. | $25.86 | 04/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022828857 | CMS |
| Alkermes, Inc. | $25.14 | 07/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022828859 | CMS |
| BioXcel Therapeutics, Inc. | $12.72 | 04/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1057513197 | CMS |
| BioXcel Therapeutics, Inc. | $22.70 | 08/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1057513203 | CMS |
| Indivior Inc. | $26.72 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034231377 | CMS |
| Indivior Inc. | $28.47 | 10/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034231385 | CMS |
| Lundbeck LLC | $19.65 | 03/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032235469 | CMS |
| Lundbeck LLC | $14.58 | 07/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032235475 | CMS |
| Neurocrine Biosciences, Inc. | $29.67 | 01/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1052234565 | CMS |
| Neurocrine Biosciences, Inc. | $19.34 | 04/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1052234603 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.